Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MREO will rise by +375.54% over the next 2 Weeks and hit $1.36 by Monday, January 12, 2026. In that time frame, MREO's share price is expected to range between $1.03 and $1.66.
BearishAverageBullishMREO shares fell -87.65% in Monday, December 29, 2025's trading session, dropping from a previous close of $2.31 to move at $0.29. The stock demonstrated notable intraday movement (see MREO's key stats for a full breakdown), fluctuating between $0.20 and $0.30, a +49.25% trading range. While recent weeks have seen some volatility, MREO has managed to secure a -86.85% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 236.55M shares changing hands, 235.71M more than the previous session. This amounted to $67.51M in total market activity.
Will MREO Continue Its Upward Trend?
According to analyst ratings and projections for MREO, Mereo BioPharma Group plc shares are anticipated to increase by +82.80%, potentially reaching $1.66 per share by January 12, 2026. Short-term technical indicators for MREO currently suggest a bullish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the MREO stock forecast, now is a good time to buy MREO stock because its current trading price is -78.97% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MREO covering social and institutional perspectives.
MREO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MREO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 14.18% to 22.94%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 32.73%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 38.93%, signals a bearish bias in the long-term trend. Insights into MREO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Mereo BioPharma Group Short-Term Forecasts
MREO Forecast For Next 5 Days
Our algorithm anticipates Mereo BioPharma Group (MREO) stock could hit $2.22 by Jan 05, 2026. This represents a +677.51% fall from today's price, following a -85.73% change over the past five days.
MREO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Mereo BioPharma Group plc (MREO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $2.36, which would mean a +726.91% increase from the current price of $0.29. Projections for this period range from a high of $2.74 to a low of $2.04.
MREO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Mereo BioPharma Group's price over the next three months point to a rise. MREO stock is expected to peak at $8.10 on Feb 20, 2026 before potentially dipping to $6.33 on Mar 27, 2026. On average, MREO is likely to trade around $7.27 in the coming 90 days.
Mereo BioPharma Group Stock Forecast 2025
Based on our predictive models, Mereo BioPharma Group (MREO) is expected to trade between $6.34 and $6.53 throughout 2025. This would result in an average price of $6.44, potentially offering investors a +2,156.48% return from current levels.
Mereo BioPharma Group plc Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in December 2025. The price is predicted to move between $6.34 and $6.53, settling at an average of $6.44. This could translate to a +2,156.48% gain.
January 2026
Based on current market signals, Mereo BioPharma Group plc is projected to trend january 2026. We forecast a trading range from $6.42 to $7.43, with a likely average price of $7.09. Investors could expect a potential return of +2,384.23%.
February 2026
Our predictive algorithms indicate Mereo BioPharma Group plc stock may see a shift in February 2026. The expected range spans $7.27–$8.10, with an average target of $7.70. This represents a positive outlook and a possible gain of +2,597.97%.
March 2026
Analyzing established trends, Mereo BioPharma Group plc looks set to move in March 2026. Projections place the stock between $5.65 and $7.91, averaging around $7.03. This suggests a +2,363.21% gain from current levels.
April 2026
Market indicators suggest Mereo BioPharma Group plc could experience notable changes during April 2026. Prices could fluctuate within $4.61 to $7.04, with a midpoint forecast of $5.66. The stock might deliver a +1,883.18% gain.
May 2026
Forecasting for May 2026, models estimate that Mereo BioPharma Group plc may undergo key fluctuations. If trends hold, the stock might trade between $4.69 and $7.35, averaging $6.09. This signals a positive trajectory with potential returns around +2,033.85%.
June 2026
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in June 2026. The price is predicted to move between $3.82 and $7.23, settling at an average of $6.11. This could translate to a +2,040.85% gain.
July 2026
Based on current market signals, Mereo BioPharma Group plc is projected to trend july 2026. We forecast a trading range from $3.27 to $5.75, with a likely average price of $5.03. Investors could expect a potential return of +1,662.44%.
August 2026
Our predictive algorithms indicate Mereo BioPharma Group plc stock may see a shift in August 2026. The expected range spans $2.59–$6.12, with an average target of $4.92. This represents a positive outlook and a possible gain of +1,623.90%.
September 2026
Analyzing established trends, Mereo BioPharma Group plc looks set to move in September 2026. Projections place the stock between $1.99 and $5.99, averaging around $4.57. This suggests a +1,501.26% gain from current levels.
October 2026
Market indicators suggest Mereo BioPharma Group plc could experience notable changes during October 2026. Prices could fluctuate within $1.35 to $6.11, with a midpoint forecast of $4.85. The stock might deliver a +1,599.37% gain.
November 2026
Forecasting for November 2026, models estimate that Mereo BioPharma Group plc may undergo key fluctuations. If trends hold, the stock might trade between $0.58 and $5.88, averaging $4.12. This signals a positive trajectory with potential returns around +1,343.59%.
December 2026
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.07 and $6.91, settling at an average of $4.72. This could translate to a +1,553.82% gain.
MREO's history of dividends and stock splits also plays a role in long-term investor confidence.

